Paul K. Whelton

2 weeks ago | healio.com | Erik Swain |Paul K. Whelton

FDA approves first polypill for initial treatment of hypertension• The FDA approved the first polypill designed for initial treatment of hypertension. • Approval was based on the results of two positive studies presented at the European Society of Cardiology Congress. George Medicines announced the FDA approval of its triple therapy polypill for initial treatment of adults with hypertension.

Apr 16, 2024 | bmjopen.bmj.com | Brian Hutchinson |Adam Walter |Norm Campbell |Paul K. Whelton

DiscussionOur analysis of scaling hypertension care in 24 countries—across a range of income levels and regions—estimated that compared with continuation of the status quo improving the hypertension care cascade using an SBP≥140 mm Hg cut-point would save nearly 1.2 million lives over the study’s 30-year time horizon. It also identified that around 68% of those health benefits are derived from treating those at the highest risk (SBP≥160 mm Hg).

Jun 24, 2023 | ahajournals.org | Paul K. Whelton |John Flack |Aletta E Schutte |Ji-Guang Wang

Originally publishedHypertension. 2023;0AbstractClinical practice guidelines are ideally suited to the provision of advice on the prevention, diagnosis, evaluation, and management of high blood pressure (BP). The recently published European Society of Hypertension (ESH) 2023 ESH Guidelines for the management of arterial hypertension is the latest in a long series of high BP clinical practice guidelines.